- Home
- DERM vs LGI Comparison
DERM vs LGI Comparison
Compare DERM & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- LGI
- Stock Information
- Founded
- DERM 2014
- LGI 2004
- Country
- DERM United States
- LGI United States
- Employees
- DERM N/A
- LGI N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- DERM Health Care
- LGI
- Exchange
- DERM Nasdaq
- LGI Nasdaq
- Market Cap
- DERM 181.0M
- LGI 210.5M
- IPO Year
- DERM 2021
- LGI N/A
- Fundamental
- Price
- DERM $8.06
- LGI $16.19
- Analyst Decision
- DERM Strong Buy
- LGI
- Analyst Count
- DERM 2
- LGI 0
- Target Price
- DERM $10.00
- LGI N/A
- AVG Volume (30 Days)
- DERM 103.3K
- LGI 41.1K
- Earning Date
- DERM 05-14-2025
- LGI 01-01-0001
- Dividend Yield
- DERM N/A
- LGI 7.10%
- EPS Growth
- DERM N/A
- LGI N/A
- EPS
- DERM N/A
- LGI N/A
- Revenue
- DERM $56,243,000.00
- LGI N/A
- Revenue This Year
- DERM $29.83
- LGI N/A
- Revenue Next Year
- DERM $54.88
- LGI N/A
- P/E Ratio
- DERM N/A
- LGI N/A
- Revenue Growth
- DERM N/A
- LGI N/A
- 52 Week Low
- DERM $3.54
- LGI $12.66
- 52 Week High
- DERM $8.24
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- DERM 65.90
- LGI 62.72
- Support Level
- DERM $6.55
- LGI $15.93
- Resistance Level
- DERM $7.00
- LGI $16.29
- Average True Range (ATR)
- DERM 0.63
- LGI 0.20
- MACD
- DERM 0.13
- LGI -0.01
- Stochastic Oscillator
- DERM 92.41
- LGI 86.11
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.